Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity ANVS - Annovis Bio, Inc.
10.2 M
LAST VALUE
-52.89%
2 YEAR CAGR
188.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR